Andrzej Frączyk

2PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.

|Aug 12, 2022
Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene-Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC.

Jolanta Kryczka, Jakub Kryczka, Łukasz Janczewski

Pageof 1

Frequent Collaborators

2 joint publications

Jolanta Kryczka

2 joint publications

Jakub Mateusz Kryczka

2 joint publications

Łukasz Janczewski

2 joint publications

Joanna Boncela

2 joint publications

Beata Kolesińska

2 joint publications

Ewa Brzeziańska-Lasota

1 joint publications

Sho Shimida

Frequent Collaborators

2 joint publications

Jolanta Kryczka

2 joint publications

Jakub Mateusz Kryczka

2 joint publications

Łukasz Janczewski

2 joint publications

Joanna Boncela

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us